RIFYX Performance — Victory RS Science & Technology Fund, Class Y
Data updated: 2026-08-26
RIFYX returned +22.83% year to date and +38.86% over one year to Jun 2026. Annualised returns are +27.76% over 3 years and +5.17% over 5 years. The fund trailed its Technology Equity category average: $100 invested three years ago grew to $209, against $225 for the category, and to $139 over one year, against $146. Volatility over the past three years was 23.55% a year. In the 12 months to Jun 2026 the fund lost a net $17.4M, and assets reached $253.38M.
RIFYX Growth of $100
What $100 invested in Victory RS Science & Technology Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Technology Equity category average over the same months.
| Period | RIFYX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $139 | $146 |
| 3 years (Jul 2023 – Jun 2026) | $209 | $225 |
| 5 years (Jul 2021 – Jun 2026) | $129 | $201 |
| Since data start (Jul 2019 – Jun 2026) | $238 | $379 |
RIFYX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +22.83% |
| 1 year | +38.86% |
| 3 years (annualised) | +27.76% |
| 5 years (annualised) | +5.17% |
RIFYX Annual Returns
Calendar-year total returns of Victory RS Science & Technology Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +22.83% |
| 2025 | +18.99% |
| 2024 | +33.21% |
| 2023 | +32.89% |
| 2022 | −43.37% |
| 2021 | −9.03% |
| 2020 | +65.39% |
| 2019 (Jul–Dec) | +7.74% |
RIFYX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −2.4% | −3.8% | −4.4% | +18.1% | +13.9% | +1.8% | — | — | — | — | — | — |
| 2025 | +4.1% | −6.1% | −13.0% | +4.0% | +9.0% | +9.2% | +2.9% | +1.7% | +5.9% | +4.0% | −1.3% | −0.6% |
| 2024 | +1.6% | +9.2% | +1.3% | −7.1% | +4.3% | +5.0% | −0.8% | +4.7% | +2.9% | +1.2% | +12.0% | −3.9% |
| 2023 | +9.3% | −1.8% | +3.7% | −2.4% | +7.0% | +6.8% | +3.4% | −3.3% | −7.1% | −7.4% | +12.4% | +10.8% |
| 2022 | −16.5% | −5.3% | −0.3% | −17.4% | −5.7% | −5.1% | +9.6% | −3.1% | −9.7% | +2.4% | +5.0% | −5.8% |
| 2021 | +0.4% | +5.5% | −6.9% | +2.7% | −4.7% | +7.3% | −3.5% | +1.4% | −7.0% | +4.1% | −5.4% | −2.0% |
| 2020 | +1.5% | −4.1% | −14.6% | +18.4% | +12.7% | +6.9% | +3.9% | +5.5% | −2.3% | +2.5% | +15.1% | +10.5% |
| 2019 | — | — | — | — | — | — | +2.7% | −5.2% | −5.2% | +3.6% | +7.4% | +5.0% |
RIFYX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 23.55%
- 3-year Sharpe ratio: 0.99 (vs 4.5% risk-free rate)
- Best month: +18.12% (Apr 2026)
- Worst month: −12.98% (Mar 2025)
RIFYX Fund Flows
Monthly money in and out of Victory RS Science & Technology Fund, from SEC Form N-PORT.
- 12-month net flow: −$17.4M
- 12-month gross sales (incl. reinvestments): $14.6M
- Sales ÷ redemptions: 0.46×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $991K | $3.1M | −$2.1M |
| May 2026 | $497K | $2.0M | −$1.5M |
| Apr 2026 | $1.0M | $2.5M | −$1.5M |
| Mar 2026 | $785K | $2.8M | −$2.1M |
| Feb 2026 | $643K | $3.3M | −$2.7M |
| Jan 2026 | $940K | $2.0M | −$1.0M |
| Dec 2025 | $6.2M | $2.5M | $3.7M |
| Nov 2025 | $672K | $2.5M | −$1.8M |
| Oct 2025 | $1.1M | $3.0M | −$1.9M |
| Sep 2025 | $438K | $2.8M | −$2.4M |
| Aug 2025 | $844K | $2.9M | −$2.0M |
| Jul 2025 | $478K | $2.6M | −$2.1M |
RIFYX Assets Under Management
Net assets of Victory RS Science & Technology Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $253.38M |
| 2026-03-31 | $189.20M |
| 2025-12-31 | $217.13M |
| 2025-09-30 | $217.88M |
| 2025-06-30 | $203.02M |
| 2025-03-31 | $168.85M |
| 2024-12-31 | $204.87M |
| 2024-09-30 | $191.47M |
| 2024-06-30 | $185.80M |
| 2024-03-31 | $190.11M |
| 2023-12-31 | $175.51M |
| 2023-09-30 | $162.33M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.